These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20090125)

  • 21. Slow accumulation of HIV resistance mutations: implications for resource-limited settings?
    Stevens WS
    J Infect Dis; 2009 Sep; 200(5):670-2. PubMed ID: 19604045
    [No Abstract]   [Full Text] [Related]  

  • 22. Crunch time for funding of universal access to antiretroviral treatment for people with HIV infection.
    Maher D; von Schoen-Angerer T; Cohn J
    Int J Clin Pract; 2011 Aug; 65(8):824-7. PubMed ID: 21762306
    [No Abstract]   [Full Text] [Related]  

  • 23. Initiative to promote access to quality HIV medicines releases first batch of results today.
    J Adv Nurs; 2002 Aug; 39(3):215. PubMed ID: 12174834
    [No Abstract]   [Full Text] [Related]  

  • 24. New frontier of AIDS activism: international trade rules and global access to medicines. Interview by John S. James.
    Sawyer E
    AIDS Treat News; 1999 Apr; (No 317):1, 5-8. PubMed ID: 11366992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New guidelines increase access to HIV/AIDS medication.
    AORN J; 2002 Sep; 76(3):448. PubMed ID: 12382663
    [No Abstract]   [Full Text] [Related]  

  • 26. The K65R mutation: selection, frequency, and possible consequences.
    Moyle GJ
    AIDS Read; 2004 Nov; 14(11):595-7, 601-3. PubMed ID: 15570671
    [No Abstract]   [Full Text] [Related]  

  • 27. Experts clash over likely impact of cheap AIDS drugs in Africa.
    Wadman M
    Nature; 2001 Apr; 410(6829):615-6. PubMed ID: 11287906
    [No Abstract]   [Full Text] [Related]  

  • 28. [Access to treatment of HIV/AIDS in the South: the challenges of sustainability].
    Kazatchkine M; Moatti JP
    Med Sci (Paris); 2008 Dec; 24(12):1007-8. PubMed ID: 19116101
    [No Abstract]   [Full Text] [Related]  

  • 29. HIV drug resistance and you. Resistance overview. A look at the basics.
    Munk B
    Posit Aware; 2006; Spec No():6-9. PubMed ID: 16583502
    [No Abstract]   [Full Text] [Related]  

  • 30. HIV/AIDS: Latin America & Caribbean. Brazil: ten years after.
    Cohen J
    Science; 2006 Jul; 313(5786):484-7. PubMed ID: 16873654
    [No Abstract]   [Full Text] [Related]  

  • 31. Successful application of laboratory tools for the detection of HIV drug resistance in routine clinical care in Georgia.
    Chkhartishvili N; Dvali N; Gochitashvili N; Sharvadze L; Tsertsvadze T
    Georgian Med News; 2008 Dec; (165):16-22. PubMed ID: 19124911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose reduction of antiretrovirals: a feasible and testable approach to expand HIV treatment in developing countries.
    Vento S; Lanzafame M; Lattuada E; Cainelli F; Restelli U; Foglia E
    Trop Med Int Health; 2013 Jan; 18(1):40-4. PubMed ID: 23094787
    [No Abstract]   [Full Text] [Related]  

  • 33. The benefits of HIV resistance testing in optimizing drug discovery.
    Heilek-Snyder G; Bean P
    Am Clin Lab; 2002 Oct; 21(8):13-4. PubMed ID: 12440169
    [No Abstract]   [Full Text] [Related]  

  • 34. HIV resistance and the developing world.
    Gupta RK; Pillay D
    Int J Antimicrob Agents; 2007 May; 29(5):510-7. PubMed ID: 17346940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The (political) economics of antiretroviral treatment in developing countries.
    Nattrass NJ
    Trends Microbiol; 2008 Dec; 16(12):574-9. PubMed ID: 18964022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV chemotherapy.
    Richman DD
    Nature; 2001 Apr; 410(6831):995-1001. PubMed ID: 11309630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Global HIV Drug Resistance Surveillance Program: a partnership between WHO and IAS. International AIDS Society.
    Havlir D; Vella S; Hammer S
    AIDS; 2002 Jul; 16(10):7-9. PubMed ID: 12146462
    [No Abstract]   [Full Text] [Related]  

  • 38. The fight against HIV/AIDS: opportunities and challenges.
    Lulseged S; Sanders E
    Ethiop Med J; 2002 Apr; 40 Suppl 1():2p. PubMed ID: 12802825
    [No Abstract]   [Full Text] [Related]  

  • 39. [Detection of primary antiretroviral resistance in Chilean patients recently infected with human immunodeficiency virus (HIV)].
    Acevedo W; Gallardo AM; Galaz J; Afani A; Cortés E
    Rev Med Chil; 2007 Nov; 135(11):1406-13. PubMed ID: 18259651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [HIV antiretroviral agents: new threats to accessibility in developing countries].
    Nau JY
    Rev Med Suisse; 2005 Dec; 1(45):2956. PubMed ID: 16425957
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.